3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
4
Uterine Cervical Neoplasms
3
Ganglioneuroblastoma
3
Sarcoma, Ewing
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroblastoma
2
Vaginal Neoplasms
1
Stomach Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Squamous Cell Carcinoma of Head and Neck
1
Polycystic Ovary Syndrome
1
Oropharyngeal Neoplasms
1
Multiple Myeloma
1
Locally Advanced Cervical Adenocarcinoma
1
Infertility
1
Human Papillomavirus-Negative Neck Squamous Cell Carcinoma
1
Cholangiocarcinoma
1
Cervical Adenocarcinoma
1
Carcinosarcoma
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Biochemically Recurrent Prostate Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Temozolomide
8
Radiotherapy
7
Radiation
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
Vincristine
2
Specimen Handling
2
Radiotherapy, Intensity-Modulated
2
Procarbazine
2
Lomustine
2
vorasidenib
1
vocimagene amiretrorepvec
1
trametinib
1
pemigatinib
1
pembrolizumab
1
mirdametinib
1
fluorodopa F 18
1
dabrafenib
1
abexinostat
1
abemaciclib
1
Vorinostat
1
Tretinoin
1
Transurethral Resection of Bladder
1
Surgical Procedures, Operative
1
Standard of Care
1
Spinal Puncture
1
Restraint, Physical
1
Radiotherapy, Conformal
1
Protons
1
Proton Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oligodendroglioma
×
Congresses as Topic
×
1 year
×
Clear all
No trials found.